Takemi Tanaka Selected Research

Takemi Tanaka Research Topics

Disease

28	Neoplasms (Cancer) 06/2022 - 09/2003
12	Breast Neoplasms (Breast Cancer) 01/2022 - 02/2009
8	Neoplasm Metastasis (Metastasis) 03/2020 - 10/2010
4	Ovarian Neoplasms (Ovarian Cancer) 03/2016 - 05/2010
3	Carcinoma (Carcinomatosis) 01/2013 - 06/2009
2	Circulating Neoplastic Cells 01/2018 - 12/2016
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2018 - 10/2004
1	Residual Neoplasm 03/2020
1	Macular Degeneration (Age-Related Maculopathy) 03/2018
1	Cicatrix (Scar) 01/2018
1	Inflammation (Inflammations) 08/2017
1	Hypoxia (Hypoxemia) 10/2016
1	Lymphoma (Lymphomas) 09/2013
1	Hodgkin Disease (Hodgkin's Disease) 08/2013
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 08/2013
1	Sclerosis 08/2013
1	Acidosis 01/2013
1	Diabetic Cardiomyopathies 05/2011
1	Hyperglycemia 05/2011
1	Arteriosclerosis 01/2008
1	Hematologic Diseases (Blood Diseases) 10/2004
1	Lung Neoplasms (Lung Cancer) 10/2004
1	Hyperplasia 09/2003
1	Papilloma (Papillomatosis) 09/2003
1	Carcinogenesis 09/2003

Drug/Important Bio-Agent (IBA)

8	E-SelectinIBA 03/2020 - 09/2010
5	Proteins (Proteins, Gene)FDA Link 06/2018 - 01/2007
4	Biomarkers (Surrogate Marker)IBA 06/2018 - 08/2013
3	Hormones (Hormone)IBA 10/2021 - 06/2015
3	Messenger RNA (mRNA)IBA 06/2018 - 12/2014
3	Estrogen ReceptorsIBA 08/2017 - 01/2013
3	Small Interfering RNA (siRNA)IBA 01/2013 - 06/2009
2	Doxorubicin (Adriamycin)FDA LinkGeneric 03/2020 - 02/2009
2	ProlactinIBA 06/2018 - 01/2013
2	Pharmaceutical PreparationsIBA 03/2018 - 02/2009
2	Phenobarbital (Luminal)FDA Link 12/2016 - 01/2013
2	Serine Proteases (Serine Protease)IBA 03/2016 - 12/2014
2	Complementary DNA (cDNA)IBA 03/2016 - 01/2007
2	Liposomes (Liposome)IBA 01/2013 - 04/2011
2	SiliconIBA 01/2013 - 05/2010
2	Oncogene Proteins (Oncogene Protein)IBA 01/2013 - 05/2010
2	Retinoid X Receptors (Retinoid X Receptor)IBA 05/2011 - 10/2007
2	Retinoic Acid Receptors (Retinoic Acid Receptor)IBA 05/2011 - 10/2007
2	1,2-oleoylphosphatidylcholine (DOPC)IBA 05/2010 - 06/2009
1	TetraspaninsIBA 06/2022
1	IntegrinsIBA 06/2022
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 06/2022
1	Phosphotransferases (Kinase)IBA 06/2022
1	Androgen Receptors (Androgen Receptor)IBA 06/2018
1	pegaptanib (Macugen)FDA Link 03/2018
1	MicroRNAs (MicroRNA)IBA 10/2016
1	AnnexinsIBA 10/2016
1	prostasinIBA 03/2016
1	SelectinsIBA 01/2016
1	Kallikreins (Kallikrein)IBA 12/2014
1	Peptide Hydrolases (Proteases)FDA Link 12/2014
1	AntigensIBA 12/2014
1	Synthetic DrugsIBA 09/2013
1	Proteasome Endopeptidase Complex (Proteasome)IBA 09/2013
1	UbiquitinIBA 09/2013
1	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 08/2013
1	Syndecan-1 (Syndecan 1)IBA 08/2013
1	Growth Hormone (Somatotropin)IBA 01/2013
1	Epidermal Growth Factor (EGF)IBA 01/2013
1	Prolactin Receptors (Prolactin Receptor)IBA 01/2013
1	Tyrosine (L-Tyrosine)FDA Link 01/2013
1	Estrogen Receptor Modulators (Antiestrogen)IBA 01/2013
1	Facilitative Glucose Transport Proteins (Glucose Transporter)IBA 01/2013
1	Oncostatin MIBA 01/2013
1	Antineoplastic Agents (Antineoplastics)IBA 10/2010
1	Hyaluronic Acid (Hyaluronan)IBA 10/2010
1	AcidsIBA 10/2010
1	CytokinesIBA 05/2010
1	Cisplatin (Platino)FDA LinkGeneric 06/2009
1	PlatinumIBA 06/2009
1	Paclitaxel (Taxol)FDA LinkGeneric 02/2009
1	Biological ProductsIBA 02/2009
1	AlbuminsIBA 02/2009
1	TeaIBA 01/2008
1	LigandsIBA 10/2007
1	Indicators and Reagents (Reagents)IBA 01/2007
1	Angiogenesis InhibitorsIBA 10/2004
1	PPAR gammaIBA 10/2004
1	Thalidomide (Thalomid)FDA Link 10/2004
1	Differentiation AntigensIBA 09/2003
1	RetinoidsIBA 09/2003

Therapy/Procedure

7	Therapeutics 03/2018 - 10/2007
4	Intravenous Administration 03/2020 - 04/2011
2	Drug Therapy (Chemotherapy) 03/2020 - 06/2009
2	Intravenous Injections 12/2016 - 06/2015
1	Adjuvant Chemotherapy 01/2022
1	Segmental Mastectomy (Lumpectomy) 10/2021
1	Radiotherapy 01/2018
1	Aftercare (After-Treatment) 01/2018
1	Chemoradiotherapy 01/2018